Not sure if they are on track. These were the goals for Q1 of 2022 released in updated Presentation on 3/2/22:
- EXO-NET collaborations (AU)
- Feasibility results for SubB2M immunoassay for breast cancer
- Manufacturing agreement for SubB2M
- SubB2M publication (breast cancer)
Still a couple of days left in Q1 2022, but haven't heard of progress on any of the goals for the quarter? Hopefully we'll hear soon but not looking promising.
- Forums
- ASX - By Stock
- Ann: Update on Legal Proceedings and BARD1 Autoantibody Program
Not sure if they are on track. These were the goals for Q1 of...
-
- There are more pages in this discussion • 44 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IIQ (ASX) to my watchlist
(20min delay)
|
|||||
Last
63.0¢ |
Change
0.045(7.69%) |
Mkt cap ! $69.47M |
Open | High | Low | Value | Volume |
58.5¢ | 63.5¢ | 58.5¢ | $149.7K | 242.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 858 | 63.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
64.0¢ | 15000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 858 | 0.630 |
1 | 5000 | 0.625 |
1 | 16000 | 0.615 |
1 | 4000 | 0.605 |
2 | 26500 | 0.600 |
Price($) | Vol. | No. |
---|---|---|
0.640 | 15000 | 1 |
0.650 | 4750 | 1 |
0.655 | 168 | 1 |
0.660 | 16129 | 1 |
0.670 | 19911 | 2 |
Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
Featured News
IIQ (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online